Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(γ-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety

International Journal of Pharmaceutics

Volumn 296, Issue 1-2, 2005, Pages 151-161

  Jeong, Young Il ^a   Seo, Seog Jin ^b   Park, In Kyu ^b   Lee, Hyun Chul ^a   Kang, In Chul ^c   Akaike, Toshihiro ^d   Cho, Chong Su ^b  

^a Chonnam National University Medical School   (South Korea)

^b Seoul National University   (South Korea)

^c Chonnam National University   (South Korea)

^d TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

HepG2; Liver specific targeting; Nanoparticles; Paclitaxel

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; CADMIUM CHLORIDE; COPOLYMER; DEUTERIUM; GALACTOSE; LECTIN; NANOPARTICLE; PACLITAXEL; POLY(GAMMA BENZYLGLUTAMATE) POLYETHYLENE GLYCOL COPOLYMER; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; FLOW CYTOMETRY; HEPATOMA CELL; HUMAN; HUMAN CELL; LEUKEMIA P 388; LIGHT SCATTERING; LIVER; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CELL COMMUNICATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GALACTOSE; LEUKEMIA P388; MICE; NANOSTRUCTURES; PACLITAXEL; POLYETHYLENE GLYCOLS; POLYGLUTAMIC ACID; POLYMERS;

EID: 18844389468     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.02.027     Document Type: Article

References (43)

1. E. Alleman, R. Gurny, and E. Doelker Drug-loaded nanoparticles - preparation methods and drug targeting issues Eur. J. Pharm. Biopharm. 39 1993 173 191
2. G. Ashwell, and J. Harford Carbohydrate-specific receptors of the liver Annu. Rev. Biochem. 51 1982 531 554
3. G. Blume, G. Cevc, M.D.J.A.I. Crommelin, A.J.M. Bakker-Woudenberg, C. Kluft, and G. Storm Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times Biochim. Biophys. Acta 1149 1993 180 184
4. C.S. Cho, and S.U. Kim Biodegradation of poly(γ-benzyl l-glutamate)/poly(ethylene glycol) block copolymer in vitro J. Control. Release 7 1988 283 286
5. C.S. Cho, S.J. Chung, M. Goto, A. Kobayashi, and T. Akaike Synthesis of poly(γ-benzyl l-glutamate)/poly(ethylene oxide) diblock copolymer encapped with sugar moiety for cell-specific biomaterials Chem. Lett. 1994 1817 1820
6. C.S. Cho, J.W. Na, Y.I. Jeong, S.H. Kim, Y.M. Lee, and Y.K. Sung Micelle formation of the hexablock copolymer consisting of poly(γ-benzyl l-glutamate) as the hydrophobic part and poly(ethylene oxide) as the hydrophilic part Polymer (Korea) 19 1995 926 931
7. C.S. Cho, J.B. Cheon, Y.I. Jeong, I.S. Kim, S.H. Kim, and T. Akaike Novel core-shell type thermo-sensitive nanoparticles composed of poly(γ-benzyl l-glutamate) as the core and poly(N-isopropylacrylamide) as the shell Macromol. Rapid Commun. 18 1997 361 369
8. C.S. Cho, Y.I. Jeong, T. Ishihara, R. Takei, J.U. Park, K.H. Park, A. Maruyama, and T. Akaike Simple preparation of nanoparticles with carbohydrate-carrying polymers Biomaterials 18 1997 323 326
9. J.P. Codde, A.J. Lumsden, S. Napoli, M.A. Burton, and B.N. Gray A comparative study of the anticancer efficacy of doxorubicin carrying microspheres and liposomes using a rat liver tumour model Anticancer Res. 13 1993 539 544
10. P.R. Dragsten, D.B. Mitchell, G. Covert, and T. Baker Drug delivery using vesicles targeted to the hepatic asialoglycoprotein receptor Biochim. Biophys. Acta 926 1987 270 279
11. R. Duncan, J. Kopecek, P. Rejmanova, and J.B. Lloyd Targeting of N-(2-hydroxypropyl) methacrylamide copolymers to liver by incorporation of galactose residues Biochim. Biophys. Acta 755 1983 518 521
12. R. Duncan, L.C.W. Seymour, L. Scarlett, J.B. Lloyd, P. Rejmanova, and J. Kopecek Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactoseamine residues after intravenous administration to rats Biochim. Biophys. Acta 880 1986 62 71
13. 125I-labelled lactose-carrying polystyrene J. Control. Release 28 1994 223 233
14. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science 263 1994 1600 1603
15. J. Harford M.I. Horowitz The Glycoconjugates vol. 4 1982 Academic Press NewYork 29 54
16. 1H NMR spectroscopy Biomaterials 18 1997 27 30
17. L. Illum, S.S. Davis, C.G. Wilson, N.W. Thomas, M. Frier, and J.G. Hardy Blood clearance and organ deposition of intravenously administered colloidal particles. The effects of particle size, nature and shape Int. J. Pharm. 12 1982 135 146
18. R.W. Jansen, G. Molema, T.L. Ching, R. Oosting, G. Harms, F. Moolenaar, M.J. Hardonk, and D.K.F. Meijer Hepatic endocytosis of various types of mannose-terminated albumins. What is important, sugar recognition, net charge or the combination of these features J. Biol. Chem. 266 1991 3343 3348
19. Y.I. Jeong, J.B. Cheon, S.H. Kim, J.W. Nah, Y.M. Lee, Y.K. Sung, T. Akaike, and C.S. Cho Clonazepam release from core-shell type nanoparticles in vitro J. Control. Release 51 1998 169 178
20. H.J. Kim, Y.I. Jeong, S.H. Kim, Y.M. Lee, and C.S. Cho Clonazepam release from core-shell type nanoparticles in vitro Arch. Pharm. Res. 20 1997 324 329
21. K. Kobayashi, H. Sumitomo, and Y. Ina Synthesis and functions of polystyrene derivatives having pendent oligosaccharides Polym. J. 17 1985 567 575
22. J. Kopecek, and R. Duncan Targetable polymeric prodrugs J. Control. Release 6 1987 315 327
23. G.S. Kwon, M. Naito, M. Yokoyama, T. Okano, Y. Sakurai, and K. Kataoka Physical entrapment of adriamycin in AB block copolymer micelles Pharm. Res. 12 1995 192 195
24. D.D. Lasic Mixed micelles in drug delivery Nature 355 1992 279 280
25. W. Lorenz, H.J. Riemann, and A. Schmal Histamine release in dogs by Cremophor EL and its derivatives: oxyethylated oleic acid is the most effective constituent Agents Actions 7 1977 63 67
26. D.K.F. Meijer, and P. Sluijs Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery Pharm. Res. 6 1989 105
27. M. Nishikawa, A. Kamijo, T. Fujita, Y. Takakura, H. Sezaki, and M. Hashida Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting Pharm. Res. 10 1993 1253 1261
28. I.J. Oh, J.Y. Oh, C.S. Cho, and K.C. Lee Biodegradability of poly(γ-benzyl l-glutamate)/poly(ethylene glycol)/poly(γ-benzyl l-glutamate) block copolymer in mice Arch. Pharm. Res. 18 1995 8 11
29. K.B. O'Hare, I.C. Hume, L. Scarlett, V. Chytry, P. Kopeckova, J. Kopecek, and R. Duncan Evaluation of anticancer agents coupled to N-(2-hydroxypropyl) methacrylamide copolymers. Effect of galactose on interaction with hepatoma cells in vitro Hepatology 10 1989 207 214
30. J. O'Mullane, and A. Daw Macromolecular prodrugs: blood interactions and targeting J. Control. Release 16 1991 113 120
31. M.T. Peracchia, R. Gref, Y. Minamitake, A. Domb, N. Lotan, and R. Langer PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: investigation of their drug encapsulation and release characteristics J. Control. Release 46 1997 223 231
32. H. Ringsdorf Structure and properties of pharmacologically active polymers J. Polym. Sci. Polym. Symp. 51 1975 135 153
33. P.B. Schiff, and S.B. Horwitz Taxol stabilizes microtubules in mouse fibroblast cells Proc. Natl. Acad. Sci. U.S.A. 77 1980 1561 1565
34. A.A. Skolnick Novel treatment for liver cancer and other solid tumors show early promise JAMA 271 1994 1813 1815
35. D. Sorg, L.F. Hsu, and J.L.S. Au Binding of taxol to plastic and glass containers and protein under in vitro conditions J. Pharm. Sci. 85 1996 29 31
36. D.S. Sonnichsen, and M.V. Relling Clinical Pharmacokinetics of paclitaxel Clin. Pharmacokinet. 27 1994 256 269
37. J.R. Wands, and H.E. Blum Primary hepatocellular carcinoma N. Engl. J. Med. 325 1991 729 731
38. Y.M. Wang, H. Sato, and I. Horikoshi In vitro and in vivo evaluation of taxol release from poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate and degradation of the microspheres J. Control. Release 49 1997 157 166
39. R.B. Weiss, R.C. Donehower, P.H. Wiernik, T. Ohnuma, R.J. Gralla, D.L. Trump, R. Baker, D.A. VanEcho, D.D. VonHoff, and B. Leyland-Jones Hypersensitivity reactions from taxol J. Clin. Oncol. 8 1990 1263 1268
40. G.Y. Wu, and C.H. Wu Evidence for targeted gene delivery to HepG2 hepatoma cells in vitro Biochemistry 27 1988 887 892
41. M. Yokoyama, M. Miyauchi, N. Yamada, T. Okano, Y. Sakurai, K. Kataoka, and S. Inoue Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer Cancer Res. 50 1990 1693 1700
42. M. Yokoyama, M. Miyauchi, N. Yamada, T. Okano, Y. Sakurai, K. Kataoka, and S. Inoue Polymer micelles as novel drug carrier: adriamycin-conjugated poly(ethylene gylcol)-poly(aspartic acid) block copolymer J. Control. Release 11 1990 269 278
43. M. Yokoyama, T. Okano, Y. Sakurai, H. Ekimoto, C. Shibazaki, and K. Kataoka Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and extremely long circulation in blood Cancer Res. 51 1991 3229 3236